0000950103-16-014180.txt : 20160617 0000950103-16-014180.hdr.sgml : 20160617 20160617094948 ACCESSION NUMBER: 0000950103-16-014180 CONFORMED SUBMISSION TYPE: 424B2 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20160617 DATE AS OF CHANGE: 20160617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JPMORGAN CHASE & CO CENTRAL INDEX KEY: 0000019617 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 132624428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B2 SEC ACT: 1933 Act SEC FILE NUMBER: 333-209682 FILM NUMBER: 161719105 BUSINESS ADDRESS: STREET 1: 270 PARK AVE STREET 2: 38TH FL CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122706000 MAIL ADDRESS: STREET 1: 270 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: J P MORGAN CHASE & CO DATE OF NAME CHANGE: 20010102 FORMER COMPANY: FORMER CONFORMED NAME: CHASE MANHATTAN CORP /DE/ DATE OF NAME CHANGE: 19960402 FORMER COMPANY: FORMER CONFORMED NAME: CHEMICAL BANKING CORP DATE OF NAME CHANGE: 19920703 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JPMorgan Chase Financial Co. LLC CENTRAL INDEX KEY: 0001665650 IRS NUMBER: 475462128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B2 SEC ACT: 1933 Act SEC FILE NUMBER: 333-209682-01 FILM NUMBER: 161719106 BUSINESS ADDRESS: STREET 1: 383 MADISON AVENUE STREET 2: FLOOR 21 CITY: NEW YORK STATE: NY ZIP: 10179 BUSINESS PHONE: (212) 270-6000 MAIL ADDRESS: STREET 1: 383 MADISON AVENUE STREET 2: FLOOR 21 CITY: NEW YORK STATE: NY ZIP: 10179 424B2 1 dp66559_424b2-3p577.htm PRELIMINARY PRICING SUPPLEMENT

The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

Subject to completion dated June 17, 2016

June , 2016

Registration Statement Nos. 333-209682 and 333-209682-01; Rule 424(b)(2)

JPMorgan Chase Financial Company LLC
Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF due June 22, 2017

Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.

The notes are designed for investors who seek a Contingent Interest Payment with respect to each Review Date for which the closing price of one share of of the SPDR^® S&P^® Biotech ETF is greater than or equal to 70.00% of its Initial Value, which we refer to as an Interest Barrier.

The notes will be automatically called if the closing price of one share of the Fund on any Review Date (other than the final Review Date) is greater than or equal to the Initial Value.

Investors in the notes should be willing to accept the risk of losing some or all of their principal and the risk that no Contingent Interest Payment may be made with respect to some or all Review Dates.

Investors should also be willing to forgo fixed interest and dividend payments, in exchange for the opportunity to receive Contingent Interest Payments.

The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes.

Minimum denominations of $1,000 and integral multiples thereof

The notes are expected to price on or about June 17, 2016 and are expected to settle on or about June 22, 2016.

CUSIP: 46646EHU9

Investing in the notes involves a number of risks. See “Risk Factors” beginning on page PS-10 of the accompanying product supplement, “Risk Factors” beginning on page US-2 of the accompanying underlying supplement and “Selected Risk Considerations” beginning on page PS-4 of this pricing supplement.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to the contrary is a criminal offense.

	Price to Public (1)	Fees and Commissions (2)	Proceeds to Issuer
Per note	$1,000	$	$
Total	$	$	$
(1) See “Supplemental Use of Proceeds” in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions it receives from us to other affiliated or unaffiliated dealers. In no event will these selling commissions exceed $18.50 per $1,000 principal amount note. See “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.

If the notes priced today, the estimated value of the notes would be approximately $964.20 per $1,000 principal amount note. The estimated value of the notes, when the terms of the notes are set, will be provided in the pricing supplement and will not be less than $955.00 per $1,000 principal amount note. See “The Estimated Value of the Notes” in this pricing supplement for additional information.

The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.

Pricing supplement no. to product supplement no. 4-I dated April 15, 2016, underlying supplement no. 1-I dated April 15, 2016
and the prospectus and prospectus supplement, each dated April 15, 2016

Key Terms

Issuer: JPMorgan Chase Financial Company LLC

Guarantor: JPMorgan Chase & Co.

Fund: The SPDR^® S&P^® Biotech ETF (Bloomberg ticker: XBI)

Contingent Interest Payments:

If the notes have not been automatically called and the closing price of one share of the Fund on any Review Date is greater than or equal to the Interest Barrier, you will receive on the applicable Interest Payment Date for each $1,000 principal amount note a Contingent Interest Payment equal to at least $37.00 (equivalent to a Contingent Interest Rate of at least 14.80% per annum, payable at a rate of at least 3.70% per quarter) (to be provided in the pricing supplement).

If the closing price of one share of the Fund on any Review Date is less than the Interest Barrier, no Contingent Interest Payment will be made with respect to that Review Date.

Contingent Interest Rate: At least 14.80% per annum, payable at a rate of at least 3.70% per quarter (to be provided in the pricing supplement)

Interest Barrier/Trigger Value: 70.00% of the Initial Value

Pricing Date: On or about June 17, 2016

Original Issue Date (Settlement Date): On or about June 22, 2016

Review Dates*: September 19, 2016, December 19, 2016, March 17, 2017 and June 19, 2017 (final Review Date)

Interest Payment Dates*: September 22, 2016, December 22, 2016, March 22, 2017 and the Maturity Date

Maturity Date*: June 22, 2017

Call Settlement Date*: If the notes are automatically called on any Review Date (other than the final Review Date), the first Interest Payment Date immediately following that Review Date

* Subject to postponement in the event of a market disruption event and as described under “General Terms of Notes — Postponement of a Determination Date — Notes Linked to a Single Underlying — Notes Linked to a Single Underlying (Other Than a Commodity Index)” and “General Terms of Notes — Postponement of a Payment Date” in the accompanying product supplement

Automatic Call:

If the closing price of one share of the Fund on any Review Date (other than the final Review Date) is greater than or equal to the Initial Value, the notes will be automatically called for a cash payment, for each $1,000 principal amount note, equal to (a) $1,000 plus (b) the Contingent Interest Payment applicable to that Review Date, payable on the applicable Call Settlement Date. No further payments will be made on the notes.

Payment at Maturity:

If the notes have not been automatically called and the Final Value is greater than or equal to the Trigger Value, you will receive a cash payment at maturity, for each $1,000 principal amount note, equal to (a) $1,000 plus (b) the Contingent Interest Payment applicable to the final Review Date.

If the notes have not been automatically called and the Final Value is less than the Trigger Value, your payment at maturity per $1,000 principal amount note will be calculated as follows:

$1,000 + ($1,000 × Fund Return)

If the notes have not been automatically called and the Final Value is less than the Trigger Value, you will lose more than 30.00% of your principal amount at maturity and could lose all of your principal amount at maturity.

Fund Return:

(Final Value – Initial Value)
Initial Value

Initial Value: The closing price of one share of the Fund on the Pricing Date

Final Value: The closing price of one share of the Fund on the final Review Date

Share Adjustment Factor: The Share Adjustment Factor is referenced in determining the closing price of one share of the Fund, and is set initially at 1.0 on the Pricing Date. The Share Adjustment Factor is subject to adjustment upon the occurrence of certain events affecting the Fund. See “The Underlyings — Funds — Anti-Dilution Adjustments” in the accompanying product supplement for further information about these adjustments.

PS-1 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

How the Notes Work

Payments in Connection with Review Dates Preceding the Final Review Date

Payment at Maturity If the Notes Have Not Been Automatically Called

PS-2 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

Total Contingent Interest Payments

The table below illustrates the hypothetical total Contingent Interest Payments per $1,000 principal amount note over the term of the notes based on a hypothetical Contingent Interest Rate of 14.80% per annum, depending on how many Contingent Interest Payments are made prior to automatic call or maturity. The actual Contingent Interest Rate will be provided in the pricing supplement and will be at least 14.80% per annum.

Number of Contingent Interest Payments	Total Contingent Interest Payments
4	$148.00
3	$111.00
2	$74.00
1	$37.00
0	$0.00

Hypothetical Payout Examples

The following examples illustrate payments on the notes linked to a hypothetical Fund, assuming a range of performances for the hypothetical Fund on the Review Dates. The hypothetical payments set forth below assume the following:

an Initial Value of $100.00;

an Interest Barrier and a Trigger Value of $70.00 (equal to 70.00% of the hypothetical Initial Value); and

a Contingent Interest Rate of 14.80% per annum (payable at a rate of 3.70% per quarter).

The hypothetical Initial Value of $100.00 has been chosen for illustrative purposes only and may not represent a likely actual Initial Value. The actual Initial Value will be the closing price of one share of the Fund on the Pricing Date and will be provided in the pricing supplement. For historical data regarding the actual closing prices of the Fund, please see the historical information set forth under “The Fund” in this pricing supplement.

Each hypothetical payment set forth below is for illustrative purposes only and may not be the actual payment applicable to a purchaser of the notes. The numbers appearing in the following examples have been rounded for ease of analysis.

Example 1 — Notes are automatically called on the first Review Date.

Date	Closing Price	Payment (per $1,000 principal amount note)
First Review Date	$105.00	$1,037.00
	Total Payment	$1,037.00 (3.70% return)

Because the closing price of one share of the Fund on the first Review Date is greater than or equal to the Initial Value, the notes will be automatically called for a cash payment, for each $1,000 principal amount note, of $1,037.00 (or $1,000 plus the Contingent Interest Payment applicable to the first Review Date), payable on the applicable Call Settlement Date. No further payments will be made on the notes.

Example 2 — Notes have NOT been automatically called and the Final Value is greater than or equal to the Trigger Value.

Date	Closing Price	Payment (per $1,000 principal amount note)
First Review Date	$95.00	$37.00
Second Review Date	$85.00	$37.00
Third Review Date	$65.00	$0
Final Review Date	$90.00	$1,111.00
	Total Payment	$1,111.00 (11.10% return)

Because the notes have not been automatically called and the Final Value is greater than or equal to the Trigger Value, the payment at maturity, for each $1,000 principal amount note, will be $1,037.00. When added to the Contingent Interest Payments received with respect to the prior Review Dates, the total amount paid, for each $1,000 principal amount note, is $1,111.00.

PS-3 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

Example 3 — Notes have NOT been automatically called and the Final Value is less than the Trigger Value.

Date	Closing Price	Payment (per $1,000 principal amount note)
First Review Date	$65.00	$0
Second Review Date	$60.00	$0
Third Review Date	$55.00	$0
Final Review Date	$50.00	$500.00
	Total Payment	$500.00 (-50.00% return)

Because the notes have not been automatically called, the Final Value is less than the Trigger Value and the Fund Return is -50.00%, the payment at maturity will be $500.00 per $1,000 principal amount note, calculated as follows:

$1,000 + [$1,000 × (-50.00%)] = $500.00

The hypothetical returns and hypothetical payments on the notes shown above apply only if you hold the notes for their entire term or until automatically called. These hypotheticals do not reflect the fees or expenses that would be associated with any sale in the secondary market. If these fees and expenses were included, the hypothetical returns and hypothetical payments shown above would likely be lower.

Selected Risk Considerations

An investment in the notes involves significant risks. These risks are explained in more detail in the “Risk Factors” sections of the accompanying product supplement and underlying supplement.

YOUR INVESTMENT IN THE NOTES MAY RESULT IN A LOSS —

The notes do not guarantee any return of principal. If the notes have not been automatically called and the Final Value is less than the Trigger Value, you will lose 1% of the principal amount of your notes for every 1% that the Final Value is less than the Initial Value. Accordingly, under these circumstances, you will lose more than 30.00% of your principal amount at maturity and could lose all of your principal amount at maturity.

THE NOTES DO NOT GUARANTEE THE PAYMENT OF INTEREST AND MAY NOT PAY ANY INTEREST AT ALL —

If the notes have not been automatically called, we will make a Contingent Interest Payment with respect to a Review Date only if the closing price of one share of the Fund on that Review Date is greater than or equal to the Interest Barrier. If the closing price of one share of the Fund on that Review Date is less than the Interest Barrier, no Contingent Interest Payment will be made with respect to that Review Date. Accordingly, if the closing price of one share of the Fund on each Review Date is less than the Interest Barrier, you will not receive any interest payments over the term of the notes.

CREDIT RISKS OF JPMORGAN FINANCIAL AND JPMORGAN CHASE & CO. —

Investors are dependent on our and JPMorgan Chase & Co.’s ability to pay all amounts due on the notes. Any actual or potential change in our or JPMorgan Chase & Co.’s creditworthiness or credit spreads, as determined by the market for taking that credit risk, is likely to adversely affect the value of the notes. If we and JPMorgan Chase & Co. were to default on our payment obligations, you may not receive any amounts owed to you under the notes and you could lose your entire investment.

AS A FINANCE SUBSIDIARY, JPMORGAN FINANCIAL HAS NO INDEPENDENT OPERATIONS AND HAS LIMITED ASSETS —

As a finance subsidiary of JPMorgan Chase & Co., we have no independent operations beyond the issuance and administration of our securities. Aside from the initial capital contribution from JPMorgan Chase & Co., substantially all of our assets relate to obligations of our affiliates to make payments under loans made by us or other intercompany agreements. As a result, we are dependent upon payments from our affiliates to meet our obligations under the notes. If these affiliates do not make payments to us and we fail to make payments on the notes, you may have to seek payment under the related guarantee by JPMorgan Chase & Co., and that guarantee will rank pari passu with all other unsecured and unsubordinated obligations of JPMorgan Chase & Co.

THE APPRECIATION POTENTIAL OF THE NOTES IS LIMITED TO THE SUM OF ANY CONTINGENT INTEREST PAYMENTS THAT MAY BE PAID OVER THE TERM OF THE NOTES,

regardless of any appreciation in the price of the Fund, which may be significant. You will not participate in any appreciation in the closing price of the Fund.

PS-4 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

POTENTIAL CONFLICTS —

We and our affiliates play a variety of roles in connection with the notes. In performing these duties, our and JPMorgan Chase & Co.’s economic interests are potentially adverse to your interests as an investor in the notes. It is possible that hedging or trading activities of ours or our affiliates in connection with the notes could result in substantial returns for us or our affiliates while the value of the notes declines. Please refer to “Risk Factors — Risks Relating to Conflicts of Interest” in the accompanying product supplement.

THE BENEFIT PROVIDED BY THE TRIGGER VALUE MAY TERMINATE ON THE FINAL REVIEW DATE —

If the Final Value is less than the Trigger Value and the notes have not been automatically called, the benefit provided by the Trigger Value will terminate and you will be fully exposed to any depreciation in the Fund.

THE AUTOMATIC CALL FEATURE MAY FORCE A POTENTIAL EARLY EXIT —

If your notes are automatically called, the term of the notes may be reduced to as short as approximately three months and you will not receive any Contingent Interest Payments after the applicable Call Settlement Date. There is no guarantee that you would be able to reinvest the proceeds from an investment in the notes at a comparable return and/or with a comparable interest rate for a similar level of risk. Even in cases where the notes are called before maturity, you are not entitled to any fees and commissions described on the front cover of this pricing supplement.

YOU WILL NOT RECEIVE DIVIDENDS ON THE FUND OR THE SECURITIES HELD BY THE FUND OR HAVE ANY RIGHTS WITH RESPECT TO THE FUND OR THOSE SECURITIES.

THERE ARE RISKS ASSOCIATED WITH THE FUND —

The Fund is subject to management risk, which is the risk that the investment strategies of the Fund’s investment adviser, the implementation of which is subject to a number of constraints, may not produce the intended results. These constraints could adversely affect the market price of the shares of the Fund and, consequently, the value of the notes.

THE PERFORMANCE AND MARKET VALUE OF THE FUND, PARTICULARLY DURING PERIODS OF MARKET VOLATILITY, MAY NOT CORRELATE WITH THE PERFORMANCE OF THE FUND’S UNDERLYING INDEX AS WELL AS THE NET ASSET VALUE PER SHARE —

The Fund does not fully replicate its Underlying Index (as defined under “The Fund” below) and may hold securities different from those included in its Underlying Index. In addition, the performance of the Fund will reflect additional transaction costs and fees that are not included in the calculation of its Underlying Index. All of these factors may lead to a lack of correlation between the performance of the Fund and its Underlying Index. In addition, corporate actions with respect to the equity securities underlying the Fund (such as mergers and spin-offs) may impact the variance between the performances of the Fund and its Underlying Index. Finally, because the shares of the Fund are traded on a securities exchange and are subject to market supply and investor demand, the market value of one share of the Fund may differ from the net asset value per share of the Fund.

During periods of market volatility, securities underlying the Fund may be unavailable in the secondary market, market participants may be unable to calculate accurately the net asset value per share of the Fund and the liquidity of the Fund may be adversely affected. This kind of market volatility may also disrupt the ability of market participants to create and redeem shares of the Fund. Further, market volatility may adversely affect, sometimes materially, the prices at which market participants are willing to buy and sell shares of the Fund. As a result, under these circumstances, the market value of shares of the Fund may vary substantially from the net asset value per share of the Fund. For all of the foregoing reasons, the performance of the Fund may not correlate with the performance of its Underlying Index as well as the net asset value per share of the Fund, which could materially and adversely affect the value of the notes in the secondary market and/or reduce any payment on the notes.

RISKS ASSOCIATED WITH THE BIOTECHNOLOGY INDUSTRY —

All or substantially all of the equity securities held by the Fund are issued by companies whose primary line of business is directly associated with the biotechnology industry. As a result, the value of the notes may be subject to greater volatility and be more adversely affected by a single economic, political or regulatory occurrence affecting this industry than a different investment linked to securities of a more broadly diversified group of issuers. Companies within the biotechnology industry invest heavily in research and development, which may not necessarily lead to commercially successful products. This industry is also subject to increased governmental regulation which may delay or inhibit the release of new products. Many biotechnology companies are dependent upon their ability to use and enforce intellectual property rights and patents. Any impairment of these rights may have adverse financial consequences. Biotechnology stocks, especially those of smaller, less-seasoned companies, tend to be more volatile than the overall market. Biotechnology companies can be significantly affected by technological change and obsolescence, product liability lawsuits and consequential high insurance costs. These factors could affect the biotechnology industry and could

PS-5 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

affect the value of the equity securities held by the Fund and the price of the Fund during the term of the notes, which may adversely affect the value of your notes.

THE ANTI-DILUTION PROTECTION FOR THE FUND IS LIMITED —

The calculation agent will make adjustments to the Share Adjustment Factor for certain events affecting the shares of the Fund. However, the calculation agent will not make an adjustment in response to all events that could affect the shares of the Fund. If an event occurs that does not require the calculation agent to make an adjustment, the value of the notes may be materially and adversely affected.

THE RISK OF THE CLOSING PRICE OF THE FUND FALLING BELOW THE INTEREST BARRIER OR THE TRIGGER VALUE IS GREATER IF THE PRICE OF THE FUND IS VOLATILE.

LACK OF LIQUIDITY —

The notes will not be listed on any securities exchange. Accordingly, the price at which you may be able to trade your notes is likely to depend on the price, if any, at which JPMS is willing to buy the notes. You may not be able to sell your notes. The notes are not designed to be short-term trading instruments. Accordingly, you should be able and willing to hold your notes to maturity.

THE FINAL TERMS AND VALUATION OF THE NOTES WILL BE PROVIDED IN THE PRICING SUPPLEMENT —

You should consider your potential investment in the notes based on the minimums for the estimated value of the notes and the Contingent Interest Rate.

THE ESTIMATED VALUE OF THE NOTES WILL BE LOWER THAN THE ORIGINAL ISSUE PRICE (PRICE TO PUBLIC) OF THE NOTES —

The estimated value of the notes is only an estimate determined by reference to several factors. The original issue price of the notes will exceed the estimated value of the notes because costs associated with selling, structuring and hedging the notes are included in the original issue price of the notes. These costs include the selling commissions, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the notes and the estimated cost of hedging our obligations under the notes. See “The Estimated Value of the Notes” in this pricing supplement.

THE ESTIMATED VALUE OF THE NOTES DOES NOT REPRESENT FUTURE VALUES OF THE NOTES AND MAY DIFFER FROM OTHERS’ ESTIMATES —

See “The Estimated Value of the Notes” in this pricing supplement.

THE ESTIMATED VALUE OF THE NOTES IS DERIVED BY REFERENCE TO AN INTERNAL FUNDING RATE —

The internal funding rate used in the determination of the estimated value of the notes is based on, among other things, our and our affiliates’ view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes in comparison to those costs for the conventional fixed-rate debt of JPMorgan Chase & Co. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the notes and any secondary market prices of the notes. See “The Estimated Value of the Notes” in this pricing supplement.

THE VALUE OF THE NOTES AS PUBLISHED BY JPMS (AND WHICH MAY BE REFLECTED ON CUSTOMER ACCOUNT STATEMENTS) MAY BE HIGHER THAN THE THEN-CURRENT ESTIMATED VALUE OF THE NOTES FOR A LIMITED TIME PERIOD —

We generally expect that some of the costs included in the original issue price of the notes will be partially paid back to you in connection with any repurchases of your notes by JPMS in an amount that will decline to zero over an initial predetermined period. See “Secondary Market Prices of the Notes” in this pricing supplement for additional information relating to this initial period. Accordingly, the estimated value of your notes during this initial period may be lower than the value of the notes as published by JPMS (and which may be shown on your customer account statements).

SECONDARY MARKET PRICES OF THE NOTES WILL LIKELY BE LOWER THAN THE ORIGINAL ISSUE PRICE OF THE NOTES —

Any secondary market prices of the notes will likely be lower than the original issue price of the notes because, among other things, secondary market prices take into account our internal secondary market funding rates for structured debt issuances and, also, because secondary market prices (a) exclude selling commissions and (b) may exclude projected hedging profits, if any, and estimated hedging costs that are included in the original issue price of the notes. As a result, the price, if any, at which JPMS will

PS-6 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

be willing to buy the notes from you in secondary market transactions, if at all, is likely to be lower than the original issue price. Any sale by you prior to the Maturity Date could result in a substantial loss to you.

SECONDARY MARKET PRICES OF THE NOTES WILL BE IMPACTED BY MANY ECONOMIC AND MARKET FACTORS —

The secondary market price of the notes during their term will be impacted by a number of economic and market factors, which may either offset or magnify each other, aside from the selling commissions, projected hedging profits, if any, estimated hedging costs and the price of the Fund. Additionally, independent pricing vendors and/or third party broker-dealers may publish a price for the notes, which may also be reflected on customer account statements. This price may be different (higher or lower) than the price of the notes, if any, at which JPMS may be willing to purchase your notes in the secondary market. See “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Notes — Secondary market prices of the notes will be impacted by many economic and market factors” in the accompanying product supplement.

The Fund

The Fund is an exchange-traded fund of the SPDR^® Series Trust, a registered investment company, that seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index, which we refer to as the Underlying Index with respect to the Fund. The Underlying Index for the Fund is currently the S&P Biotechnology Select Industry^TM Index. The S&P Biotechnology Select Industry^TM Index is a modified equal-weight index that is designed to measure the performance of the GICS® biotechnology sub-industry. The S&P Biotechnology Select Industry^TM Index may also include companies in the life sciences tools & services sub-industry. For additional information about the Fund, see the information set forth under “Fund Descriptions — The SPDR® S&P Industry ETFs” in the accompanying underlying supplement. For purposes of this pricing supplement, all references to an SPDR® S&P Industry ETF in the accompanying underlying supplement are deemed to include the Fund. For additional information about the S&P Biotechnology Select Industry^TM Index, see “Annex A” in this pricing supplement.

PS-7 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

Historical Information

The following graph sets forth the historical performance of the Fund based on the weekly historical closing prices of one share of the Fund from January 7, 2011 through June 10, 2016. The closing price of one share of the Fund on June 16, 2016 was $54.82. We obtained the closing prices above and below from the Bloomberg Professional^® service (“Bloomberg”), without independent verification. The closing prices below may have been adjusted by Bloomberg for actions taken by the Fund, such as stock splits.

The historical closing prices of one share of the Fund should not be taken as an indication of future performance, and no assurance can be given as to the closing price of one share of the Fund on the Pricing Date or any Review Date. There can be no assurance that the performance of the Fund will result in the return of any of your principal amount or the payment of any interest.

Tax Treatment

You should review carefully the section entitled “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement no. 4-I. In determining our reporting responsibilities we intend to treat (i) the notes for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons and (ii) any Contingent Interest Payments as ordinary income, as described in the section entitled “Material U.S. Federal Income Tax Consequences — Tax Consequences to U.S. Holders — Notes Treated as Prepaid Forward Contracts with Associated Contingent Coupons” in the accompanying product supplement. Based on the advice of Davis Polk & Wardwell LLP, our special tax counsel, we believe that this is a reasonable treatment, but that there are other reasonable treatments that the IRS or a court may adopt, in which case the timing and character of any income or loss on the notes could be materially affected. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying property to which the instruments are linked. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially affect the tax consequences of an investment in the notes, possibly with retroactive effect. You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the notes, including possible alternative treatments and the issues presented by this notice.

Non-U.S. Holders — Tax Considerations. The U.S. federal income tax treatment of Contingent Interest Payments is uncertain, and although we believe it is reasonable to take a position that Contingent Interest Payments are not subject to U.S. withholding tax (at least if an applicable Form W-8 is provided), a withholding agent may nonetheless withhold on these payments (generally at a rate of 30%, subject to the possible reduction of that rate under an applicable income tax treaty), unless income from your notes is effectively connected with your conduct of a trade or business in the United States (and, if an applicable treaty so requires, attributable to a permanent establishment in the United States). If you are not a United States person, you are urged to consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the notes in light of your particular circumstances.

PS-8 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

Non-U.S. holders should also note that recently promulgated Treasury regulations imposing a withholding tax on certain “dividend equivalents” under certain “equity linked instruments” generally will not apply to the notes.

FATCA. Withholding under legislation commonly referred to as “FATCA” could apply to payments with respect to the notes that are treated as U.S.-source “fixed or determinable annual or periodical” income (“FDAP Income”) for U.S. federal income tax purposes (such as interest, if the notes are recharacterized, in whole or in part, as debt instruments, or Contingent Interest Payments if they are otherwise treated as FDAP Income). Under a recent IRS notice, withholding under FATCA will not apply to payments of gross proceeds (other than any amount treated as FDAP Income) of a taxable disposition, including an early redemption or redemption at maturity, of the notes. You should consult your tax adviser regarding the potential application of FATCA to the notes.

In the event of any withholding on the notes, we will not be required to pay any additional amounts with respect to amounts so withheld.

The Estimated Value of the Notes

The estimated value of the notes set forth on the cover of this pricing supplement is equal to the sum of the values of the following hypothetical components: (1) a fixed-income debt component with the same maturity as the notes, valued using the internal funding rate described below, and (2) the derivative or derivatives underlying the economic terms of the notes. The estimated value of the notes does not represent a minimum price at which JPMS would be willing to buy your notes in any secondary market (if any exists) at any time. The internal funding rate used in the determination of the estimated value of the notes is based on, among other things, our and our affiliates’ view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes in comparison to those costs for the conventional fixed-rate debt of JPMorgan Chase & Co. For additional information, see “Selected Risk Considerations — The Estimated Value of the Notes Is Derived by Reference to an Internal Funding Rate” in this pricing supplement.

The value of the derivative or derivatives underlying the economic terms of the notes is derived from internal pricing models of our affiliates. These models are dependent on inputs such as the traded market prices of comparable derivative instruments and on various other inputs, some of which are market-observable, and which can include volatility, dividend rates, interest rates and other factors, as well as assumptions about future market events and/or environments. Accordingly, the estimated value of the notes is determined when the terms of the notes are set based on market conditions and other relevant factors and assumptions existing at that time.

The estimated value of the notes does not represent future values of the notes and may differ from others’ estimates. Different pricing models and assumptions could provide valuations for the notes that are greater than or less than the estimated value of the notes. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be incorrect. On future dates, the value of the notes could change significantly based on, among other things, changes in market conditions, our or JPMorgan Chase & Co.’s creditworthiness, interest rate movements and other relevant factors, which may impact the price, if any, at which JPMS would be willing to buy notes from you in secondary market transactions.

The estimated value of the notes will be lower than the original issue price of the notes because costs associated with selling, structuring and hedging the notes are included in the original issue price of the notes. These costs include the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the notes and the estimated cost of hedging our obligations under the notes. Because hedging our obligations entails risk and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or it may result in a loss. A portion of the profits, if any, realized in hedging our obligations under the notes may be allowed to other affiliated or unaffiliated dealers, and we or one or more of our affiliates will retain any remaining hedging profits. See “Selected Risk Considerations — The Estimated Value of the Notes Will Be Lower Than the Original Issue Price (Price to Public) of the Notes” in this pricing supplement.

Secondary Market Prices of the Notes

For information about factors that will impact any secondary market prices of the notes, see “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Notes — Secondary market prices of the notes will be impacted by many economic and market factors” in the accompanying product supplement. In addition, we generally expect that some of the costs included in the original issue price of the notes will be partially paid back to you in connection with any repurchases of your notes by JPMS in an amount that will decline to zero over an initial predetermined period. These costs can include projected hedging profits, if any, and, in some circumstances, estimated hedging costs and our internal secondary market funding rates for structured debt issuances. This initial predetermined time period is intended to be the shorter of six months and one-half of the stated term of the notes. The length of any such initial period reflects the structure of the notes, whether our affiliates expect to earn a profit in connection

PS-9 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

with our hedging activities, the estimated costs of hedging the notes and when these costs are incurred, as determined by our affiliates. See “Selected Risk Considerations — The Value of the Notes as Published by JPMS (and Which May Be Reflected on Customer Account Statements) May Be Higher Than the Then-Current Estimated Value of the Notes for a Limited Time Period” in this pricing supplement.

Supplemental Use of Proceeds

The notes are offered to meet investor demand for products that reflect the risk-return profile and market exposure provided by the notes. See “How the Notes Work” and “Hypothetical Payout Examples” in this pricing supplement for an illustration of the risk-return profile of the notes and “The Fund” in this pricing supplement for a description of the market exposure provided by the notes.

The original issue price of the notes is equal to the estimated value of the notes plus the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, plus (minus) the projected profits (losses) that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the notes, plus the estimated cost of hedging our obligations under the notes.

Additional Terms Specific to the Notes

You may revoke your offer to purchase the notes at any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to change the terms of, or reject any offer to purchase, the notes prior to their issuance. In the event of any changes to the terms of the notes, we will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.

You should read this pricing supplement together with the accompanying prospectus, as supplemented by the accompanying prospectus supplement, relating to our Series A medium-term notes of which these notes are a part, and the more detailed information contained in the accompanying product supplement and the accompanying underlying supplement. This pricing supplement, together with the documents listed below, contains the terms of the notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, fact sheets, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth in the “Risk Factors” sections of the accompanying product supplement and the accompanying underlying supplement, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the notes.

You may access these documents on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):

Product supplement no. 4-I dated April 15, 2016:

http://www.sec.gov/Archives/edgar/data/19617/000095010316012644/crt_dp64831-424b2.pdf

Underlying supplement no. 1-I dated April 15, 2016:

http://www.sec.gov/Archives/edgar/data/19617/000095010316012649/crt-dp64909_424b2.pdf

Prospectus supplement and prospectus, each dated April 15, 2016:

http://www.sec.gov/Archives/edgar/data/19617/000095010316012636/crt_dp64952-424b2.pdf

Our Central Index Key, or CIK, on the SEC website is 1665650, and JPMorgan Chase & Co.’s CIK is 19617. As used in this pricing supplement, “we,” “us” and “our” refer to JPMorgan Financial.

PS-10 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

Annex A

The S&P Biotechnology Select Industry^TM Index

We have derived all information contained in this pricing supplement regarding the S&P Biotechnology Select Industry^TM Index, including, without limitation, its make-up, method of calculation and changes in their components, from publicly available information, without independent verification. This information reflects the policies of, and is subject to change by S&P Dow Jones Indices LLC. S&P Dow Jones LLC has no obligation to continue to calculate and publish, and may discontinue calculation and publication of, the S&P Biotechnology Select Industry^TM Index.

The S&P Biotechnology Select Industry^TM Index is a modified equal-weighted index that measures the performance of the GICS^® biotechnology sub-industry. As described in the accompanying underlying supplement, the S&P Biotechnology Select Industry^TM Index may also include companies in the following supplementary sub-industry: life sciences tools & services. The S&P Biotechnology Select Industry^TM Index is reported by Bloomberg L.P. under the ticker symbol “SPSIBI.”

For more information on the index calculation methodology used to formulate the S&P Biotechnology Select Industry^TM Index, see “Equity Index Descriptions — The Select Industry Indices” in the accompanying underlying supplement. For purposes of this pricing supplement, all references to a Select Industry Index contained in the accompanying underlying supplement are deemed to include the S&P Biotechnology Select Industry^TM Index.

PS-11 | Structured Investments

Auto Callable Contingent Interest Notes Linked to the SPDR^® S&P^® Biotech ETF

GRAPHIC 2 logo1.jpg GRAPHIC begin 644 logo1.jpg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logo2.jpg GRAPHIC begin 644 logo2.jpg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dia1.jpg GRAPHIC begin 644 dia1.jpg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dia.jpg GRAPHIC begin 644 dia.jpg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sp.jpg GRAPHIC begin 644 sp.jpg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end